Moss: MORE QUESTIONS ABOUT ANTI-ANGIOGENIC DRUGS

[Guest guest]

Ralph W. Moss, Ph.D. Weekly CancerDecisions.com

Newsletter #384 03/22/09

CANCER DECISIONS FREE WEEKLY NEWSLETTER

MORE QUESTIONS ABOUT ANTI-ANGIOGENIC DRUGS

Last week I wrote about research at the University of California San

Francisco (UCSF) showing that in experimental animal systems the

anti-angiogenic drug sunitinib (Sutent) actually facilitated the spread

of cancer. This week I will describe work being done at the University

of California, San Diego (UCSD) that, while quite different in its

methodology, supports the same general conclusion.

To read this week's newsletter, please click or go to:

http://www.cancerdecisions.com/032209.html